Home CorFlow

CorFlow

In operation
Series B
Developer of Microvascular Occlusion Diagnosis and Treatment Technologies

Basic Information

CorFlow Therapeutics is a medical technology start-up developing proprietary technologies for the diagnosis and treatment of microvascular obstruction in heart disease patients. The CorFlow technology enables interventional cardiologists to diagnose and treat MVO in patients with severe heart attacks, potentially reducing short- and long-term complication rates in these patients.
CorFlow Therapeutics AG
Zug,Switzerland
15~50 people
January 01, 2016
contact@corflow-therapeutics.ch